Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders

J. C. Byrd, M. R. Grever, J. K. Waselenko, C. R. Willis, K. Park, A. Goodrich, M. A. Lucas, C. Shinn, I. W. Flinn

Research output: Contribution to journal › Article › peer-review